Effects of S-acetylglutathione in cell and animal model of herpes simplex virus type 1 infection
- 203 Downloads
Intracellular glutathione (GSH) plays an important regulatory role in the host response to viral infections. Replenishment of intracellular GSH is a desirable yet challenging goal, since systemic GSH supplementation is rather inefficient due to a short half-life of GSH in blood plasma. Further, GSH is not taken up by cells directly, but needs to be broken down into amino acids and resynthesized to GSH intracellularly, this process often being impaired during viral infections. These obstacles may be overcome by a novel glutathione derivative S-acetylglutathione (S-GSH), which is more stable in plasma and taken up directly by cells with subsequent conversion to GSH. In the present study, in vitro effects of supplementation with S-GSH or GSH on intracellular GSH levels, cell survival and replication of human herpes simplex virus type 1 (HSV-1) were studied in human foreskin fibroblasts. In addition, in vivo effects of supplementation with S-GSH or GSH on HSV-1-induced mortality were studied in hr/hr mice. In cell culture, viral infection resulted in a significant decrease of intracellular GSH levels. S-GSH efficiently and dose-dependently (5 and 10 mM tested) restored intracellular GSH, and this replenishment was more efficient than with GSH supplementation. In mice, S-GSH, but not GSH, significantly decreased HSV-1-induced mortality (P<0.05). The data suggest that S-GSH is a suitable antiviral agent against HSV-1 both in vitro and in vivo, indicating that this drug may be of benefit in the adjunctive therapy of HSV-1 infections.
KeywordsIntracellular glutathione S-acetylglutathione Herpes simplex virus type 1 infection Antiviral drugs
This research was supported in part by “Hilfe für krebskranke Kinder Frankfurt e.V.” and by the foundation “Frankfurter Stiftung für krebskranke Kinder”.
- 2.Anderson ME (1998) Glutathione: an overview of biosynthesis and modulation. Chem Biol Interact 111–112:1–14Google Scholar
- 6.Barbaro G, Di Lorenzo G, Soldini M, Parrotto S, Bellomo G, Belloni G, Grisorio B, Barbarini G (1996) Hepatic glutathione deficiency in chronic hepatitis C: quantitative evaluation in patients who are HIV positive and HIV negative and correlations with plasmatic and lymphocytic concentrations and with the activity of the liver disease. Am J Gastroenterol 91:2569–2573PubMedGoogle Scholar
- 10.Cinatl J Jr, Cinatl J, Weber B, Rabenau H, Gümbel HO, Chenot JF, Scholz M, Encke A, Doerr HW (1995) In vitro inhibition of human cytomegalovirus replication in human foreskin fibroblasts and endothelial cells by ascorbic acid 2-phosphate. Antiviral Res 27:405–418Google Scholar
- 12.Cooper AJL (1997) Glutathione in the brain: disorders of glutathione metabolism. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, Kunk LM (eds) The molecular and genetic basis of neurological disease. Butterworth-Heinemann, Boston, pp 1195–1230Google Scholar
- 14.De Rosa SC, Zaretsky MD, Dubs JG, Roederer M, Anderson M, Green A, Mitra D, Watanabe N, Nakamura H, Tjioe I, Deresinski SC, Moore WA, Ela SW, Parks D, Herzenberg LA, Herzenberg LA (2000) N-Acetylcysteine replenishes glutathione in HIV infection. Eur J Clin Invest 30:915–929CrossRefPubMedGoogle Scholar
- 15.Dringen R (2000) Metabolism and functions of glutathione in brain. Prog Neurobiol 62:649–671Google Scholar
- 19.Galzigna L, Rizzoli V, Schiapelli P, Moretto C, Bernareggi A (1995) S-Acetyl and S-phenylacetyl-glutathione as glutathione precursors in rat plasma and tissue preparations. Enzyme Protein 48:98–104Google Scholar
- 22.Helbling B, Von Overbeck J, Lauterburg BH (1994) Decreased synthesis of glutathione in patients with AIDS. Eur J Clin Invest 24:A38Google Scholar
- 32.Reed LI, Muench H (1938) A simple method of estimating fifty per cent endpoints. Am J Hyg 27:493–497Google Scholar